Biopharma and Health Related News

The ‘New Pharma’: Synthetic biology reimagines drug development

This sponsored content is made possible by Codexis. Whether it’s food ingredients, therapeutics, or high-performance enzymes, Codexis is engineering proteins better, faster, and cheaper than ever. To learn more about its revolutionary CodeEvolver platform technology, visit It’s time for [...]

Oxitec to Apply New Generation of Self-Limiting Mosquito Technology to Malaria-Spreading Mosquitoes

Oxitec’s first step into global malaria vector control efforts in partnership with the Bill & Melinda Gates Foundation Agreement covers the first strain of Oxitec’s genetically-engineered mosquitoes specifically designed to combat malaria vector Oxford, June 19, 2018– Oxitec, Ltd. [...]

RoosterBio Inc. Becomes Industry Partner in NSF-Funded Public-Private Cell Manufacturing Technologies Initiative

Engineering Research Center Aims to Revolutionize Treatment of Cancers, Diseases and Other Disorders FREDERICK, Md. (PRWEB) June 13, 2018 RoosterBio Inc. has joined the new NSF Engineering Research Center for Cell Manufacturing Technologies, known as CMaT. The center, launched in [...]

Lumen Wins Triple Funding Boost to Advance Development of Low-Cost Therapeutics for Newborns and Infants in Developing Countries

Encouraging early antibody research triggers funding increase Seattle, WA—June 13, 2018—Lumen Bioscience, a Seattle company developing novel biologics on its proprietary Spirulina expression platform, announced today that the Bill & Melinda Gates Foundation has tripled its funding commitment for Lumen’s [...]

GenScript Supports the Development of a Novel HIV Vaccine

PISCATAWAY, N.J., June 12, 2018 -- A promising experimental HIV vaccine was reported in Nature Medicine on June 4, 2018 by Kai Xu and colleagues from Drs. Mascola and Kwong labs at the Vaccine Research Center (VRC) at the National [...]

Synlogic Presents Preclinical Data from Synthetic BioticTM Medicine, SYNB1618, for the Treatment of Phenylketonuria

– SYNB1618 currently being evaluated in a Phase 1/2a clinical trial in healthy volunteers and patients with Phenylketonuria (PKU); interim data expected in 2H 2018 – – Data presented in plenary session at ASM Microbe 2018 demonstrate lowering of [...]